Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Open in API
Filings indexed 525 across all filing types
Latest filing 2023-09-29 Regulatory Filings
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
Notice.pdf
Regulatory Filings Classification · 95% confidence The document is a notice regarding a change of auditor for Therma Bright Inc., referencing National Instrument 51-102 which governs continuous disclosure obligations. It announces the resignation of the former auditor and appointment of a new auditor, approved by the Audit Committee and Board of Directors. There is no detailed audit report or financial data included, only an announcement of auditor change. The document length is short (1608 characters), and it serves as a formal notification rather than a full audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other specific categories.
2023-09-29 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing amendments to acquisition agreements involving Therma Bright Inc. It details the issuance of shares as consideration for acquiring interests in two companies, InStatin and InVixa, and mentions a finder's fee payable in shares. The document includes forward-looking statements and regulatory disclaimers typical of acquisition announcements. There is no financial report, earnings data, or management discussion. The content focuses on capital transactions and financing activities related to acquisitions. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and content do not suggest it is a full report or regulatory filing, but rather an announcement of financing-related transactions.
2023-09-27 English
Material change report - English.pdf
Regulatory Filings
2023-09-14 English
News release - English.pdf
Regulatory Filings
2023-09-13 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Therma Bright Inc. It details a material change event regarding the submission of an updated FDA 510K application for their Venowave device. The document includes specific items such as the date of material change, summary, full description, and executive officer contact, consistent with regulatory disclosure requirements for material change reports. It is not a full financial report, earnings release, or management discussion, nor is it an announcement of a report publication. The content focuses on a material change disclosure, which aligns with regulatory filings that do not fit into other specific categories. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-09-08 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Therma Bright Inc. has submitted an updated FDA 510K application to correct the intended use, labeling, and description of its Venowave device. It discusses regulatory submissions and approvals related to medical device use and coding but does not contain any financial data, earnings information, or detailed financial reports. The document is an announcement of a regulatory filing or update rather than a financial report or detailed regulatory filing like an audit or annual report. It is also not a certification or officer attestation. Given the nature of the content—an announcement about a regulatory submission related to FDA and CMS approvals—it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-09-07 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.